Jacobs Levy Equity Management’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.3M Sell
425,982
-48,151
-10% -$2.07M 0.08% 222
2025
Q4
$20.8M Buy
474,133
+1,313
+0.3% +$54.3K 0.08% 203
2025
Q3
$19.5M Sell
472,820
-535,153
-53% -$21.5M 0.08% 204
2025
Q2
$44.4M Sell
1,007,973
-407,684
-29% -$16.3M 0.17% 128
2025
Q1
$52.3M Sell
1,415,657
-90,427
-6% -$3.22M 0.21% 114
2024
Q4
$50.2M Sell
1,506,084
-576,199
-28% -$18.7M 0.18% 132
2024
Q3
$54M Sell
2,082,283
-438,900
-17% -$10.9M 0.21% 122
2024
Q2
$56.7M Buy
2,521,183
+115,234
+5% +$2.56M 0.23% 99
2024
Q1
$57.1M Buy
2,405,949
+41,036
+2% +$912K 0.26% 97
2023
Q4
$56.7M Sell
2,364,913
-935,281
-28% -$20.3M 0.29% 80
2023
Q3
$72.1M Sell
3,300,194
-77,558
-2% -$1.62M 0.43% 58
2023
Q2
$64.5M Sell
3,377,752
-31,254
-0.9% -$602K 0.37% 66
2023
Q1
$66.2M Buy
3,409,006
+211,416
+7% +$3.68M 0.41% 57
2022
Q4
$51.3M Buy
3,197,590
+631,552
+25% +$10.3M 0.35% 81
2022
Q3
$40.2M Buy
2,566,038
+246,479
+11% +$4.76M 0.32% 90
2022
Q2
$48.3M Sell
2,319,559
-79,552
-3% -$1.64M 0.37% 62
2022
Q1
$54.4M Buy
2,399,111
+155,587
+7% +$3.04M 0.37% 65
2021
Q4
$41M Buy
2,243,524
+1,018,237
+83% +$19.5M 0.27% 93
2021
Q3
$25.9M Buy
1,225,287
+1,116,242
+1,024% +$20.7M 0.17% 148
2021
Q2
$1.99M Buy
+109,045
New +$2.54M 0.01% 597
2019
Q1
Sell
-39,890
Closed -$785K 980
2018
Q4
$785K Sell
39,890
-200
-0.5% -$3.57K 0.01% 648
2018
Q3
$710K Sell
40,090
-5,490
-12% -$107K 0.01% 714
2018
Q2
$981K Sell
45,580
-21,270
-32% -$440K 0.02% 668
2018
Q1
$1.48M Buy
66,850
+17,970
+37% +$497K 0.02% 541
2017
Q4
$1.49M Buy
48,880
+15,300
+46% +$407K 0.03% 528
2017
Q3
$814K Buy
33,580
+4,670
+16% +$124K 0.02% 624
2017
Q2
$712K Buy
+28,910
New +$612K 0.02% 625

Other funds holding EXEL

Jacobs Levy Equity Management's EXEL Position: Q1 2026 in Review

Jacobs Levy Equity Management reduced its Exelixis (EXEL) stake by 10% in Q1 2026, selling an estimated $2.07M and leaving 425,982 shares worth $18.3M. The position accounts for 0.08% of the portfolio, ranked #222.

Jacobs Levy Equity Management first reported a position in EXEL in Q2 2017 and has held it in 27 quarters since. The position peaked at $72.1M in Q3 2023. 694 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • Jacobs Levy Equity Management held 425,982 shares of Exelixis worth $18.3M as of Q1 2026.
  • Jacobs Levy Equity Management sold 48,151 Exelixis shares in Q1 2026, an estimated $2.07M.
  • Exelixis made up 0.08% of Jacobs Levy Equity Management's portfolio in Q1 2026, its #222 holding.
  • Jacobs Levy Equity Management first reported a position in Exelixis in Q2 2017 and has held it in 27 quarters since.
  • Jacobs Levy Equity Management's Exelixis position peaked at $72.1M in Q3 2023.
  • 694 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2026, filed 15 May 2026.